These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
235 related items for PubMed ID: 18470646
1. Reducing the genotoxic potential of retroviral vectors. Ramezani A, Hawley TS, Hawley RG. Methods Mol Biol; 2008; 434():183-203. PubMed ID: 18470646 [Abstract] [Full Text] [Related]
2. Self-inactivating retroviral vector-mediated gene transfer induces oncogene activation and immortalization of primary murine bone marrow cells. Bosticardo M, Ghosh A, Du Y, Jenkins NA, Copeland NG, Candotti F. Mol Ther; 2009 Nov; 17(11):1910-8. PubMed ID: 19638958 [Abstract] [Full Text] [Related]
3. Improving transcriptional termination of self-inactivating gamma-retroviral and lentiviral vectors. Schambach A, Galla M, Maetzig T, Loew R, Baum C. Mol Ther; 2007 Jun; 15(6):1167-73. PubMed ID: 17406345 [Abstract] [Full Text] [Related]
4. Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity. Modlich U, Bohne J, Schmidt M, von Kalle C, Knöss S, Schambach A, Baum C. Blood; 2006 Oct 15; 108(8):2545-53. PubMed ID: 16825499 [Abstract] [Full Text] [Related]
5. Physiological promoters reduce the genotoxic risk of integrating gene vectors. Zychlinski D, Schambach A, Modlich U, Maetzig T, Meyer J, Grassman E, Mishra A, Baum C. Mol Ther; 2008 Apr 15; 16(4):718-25. PubMed ID: 18334985 [Abstract] [Full Text] [Related]
6. Foamy Virus Vector Carries a Strong Insulator in Its Long Terminal Repeat Which Reduces Its Genotoxic Potential. Goodman MA, Arumugam P, Pillis DM, Loberg A, Nasimuzzaman M, Lynn D, van der Loo JCM, Dexheimer PJ, Keddache M, Bauer TR, Hickstein DD, Russell DW, Malik P. J Virol; 2018 Jan 01; 92(1):. PubMed ID: 29046446 [Abstract] [Full Text] [Related]
7. Retroviral Insertional Mutagenesis in Humans: Evidence for Four Genetic Mechanisms Promoting Expansion of Cell Clones. Bushman FD. Mol Ther; 2020 Feb 05; 28(2):352-356. PubMed ID: 31951833 [Abstract] [Full Text] [Related]
8. Deletion of a negatively acting sequence in a chimeric GATA-1 enhancer-long terminal repeat greatly increases retrovirally mediated erythroid expression. Testa A, Lotti F, Cairns L, Grande A, Ottolenghi S, Ferrari G, Ronchi A. J Biol Chem; 2004 Mar 12; 279(11):10523-31. PubMed ID: 14701820 [Abstract] [Full Text] [Related]
9. Genotoxicity of retroviral integration in hematopoietic cells. Nienhuis AW, Dunbar CE, Sorrentino BP. Mol Ther; 2006 Jun 12; 13(6):1031-49. PubMed ID: 16624621 [Abstract] [Full Text] [Related]
10. Transcriptional enhancers induce insertional gene deregulation independently from the vector type and design. Maruggi G, Porcellini S, Facchini G, Perna SK, Cattoglio C, Sartori D, Ambrosi A, Schambach A, Baum C, Bonini C, Bovolenta C, Mavilio F, Recchia A. Mol Ther; 2009 May 12; 17(5):851-6. PubMed ID: 19293778 [Abstract] [Full Text] [Related]
11. Establishment of modified retroviral vector targeting X-linked severe combined immunodeficiency. Zhi CL, Migita M, Hayakawa J, Fukunaga Y. J Nippon Med Sch; 2004 Feb 12; 71(1):51-6. PubMed ID: 15129596 [Abstract] [Full Text] [Related]
12. Retroviral vectors: post entry events and genomic alterations. Nowrouzi A, Glimm H, von Kalle C, Schmidt M. Viruses; 2011 May 12; 3(5):429-55. PubMed ID: 21994741 [Abstract] [Full Text] [Related]
13. Aberrant Clonal Hematopoiesis following Lentiviral Vector Transduction of HSPCs in a Rhesus Macaque. Espinoza DA, Fan X, Yang D, Cordes SF, Truitt LL, Calvo KR, Yabe IM, Demirci S, Hope KJ, Hong SG, Krouse A, Metzger M, Bonifacino A, Lu R, Uchida N, Tisdale JF, Wu X, DeRavin SS, Malech HL, Donahue RE, Wu C, Dunbar CE. Mol Ther; 2019 Jun 05; 27(6):1074-1086. PubMed ID: 31023523 [Abstract] [Full Text] [Related]
14. Retroviral hybrid LTR vector strategy: functional analysis of LTR elements and generation of endothelial cell specificity. Richardson TB, Kaspers J, Porter CD. Gene Ther; 2004 May 05; 11(9):775-83. PubMed ID: 14999228 [Abstract] [Full Text] [Related]
15. Liver-directed gene therapy: a retroviral vector with a complete LTR and the ApoE enhancer-alpha 1-antitrypsin promoter dramatically increases expression of human alpha 1-antitrypsin in vivo. Okuyama T, Huber RM, Bowling W, Pearline R, Kennedy SC, Flye MW, Ponder KP. Hum Gene Ther; 1996 Mar 20; 7(5):637-45. PubMed ID: 8845389 [Abstract] [Full Text] [Related]
16. Topological constraints governing the use of the chicken HS4 chromatin insulator in oncoretrovirus vectors. Yannaki E, Tubb J, Aker M, Stamatoyannopoulos G, Emery DW. Mol Ther; 2002 May 20; 5(5 Pt 1):589-98. PubMed ID: 11991750 [Abstract] [Full Text] [Related]
17. Simplified retroviral vector gcsap with murine stem cell virus long terminal repeat allows high and continued expression of enhanced green fluorescent protein by human hematopoietic progenitors engrafted in nonobese diabetic/severe combined immunodeficient mice. Kaneko S, Onodera M, Fujiki Y, Nagasawa T, Nakauchi H. Hum Gene Ther; 2001 Jan 01; 12(1):35-44. PubMed ID: 11177540 [Abstract] [Full Text] [Related]
18. Transcriptional targeting of retroviral vectors to the erythroblastic progeny of transduced hematopoietic stem cells. Grande A, Piovani B, Aiuti A, Ottolenghi S, Mavilio F, Ferrari G. Blood; 1999 May 15; 93(10):3276-85. PubMed ID: 10233879 [Abstract] [Full Text] [Related]
19. Novel principles of gamma-retroviral insertional transcription activation in murine leukemia virus-induced end-stage tumors. Sokol M, Wabl M, Ruiz IR, Pedersen FS. Retrovirology; 2014 May 19; 11():36. PubMed ID: 24886479 [Abstract] [Full Text] [Related]
20. Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells. Baum C, Hegewisch-Becker S, Eckert HG, Stocking C, Ostertag W. J Virol; 1995 Dec 19; 69(12):7541-7. PubMed ID: 7494260 [Abstract] [Full Text] [Related] Page: [Next] [New Search]